Clinical Trials · NCT01552395
A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Ferring Pharmaceuticals
- Enrollment
- 4,136
- Start date
- Mar 2012
- Locations
- 68 sites, Czechia
- Primary endpoint
- Number of patients with adverse events